Nimbus Administration Set; Nimbus Flex; Nimbus PainPro (a.k.a. Halo Ambulatory Infusion System); Catalog Number IT1025. Ambulatory Infusion Pump and components
Published April 3, 2024 · Recall initiated: February 21, 2024
Summary
FDA records medical device Class I recall Z-1285-2024, published April 3, 2024 and initiated February 21, 2024. Recalling firm: InfuTronix LLC; Status: Ongoing; Reported quantity: 52,328 total; Lot: UDI-DI 00817170020000 Lots A100-150205200 A100-150415015 A100-150430270 A100-150611300 A100-150716620 A100D-1705191000 AZ060-171201564 AZ060-1801021020 AZ060-180609264 AZ060-180626552 AZ060-190104792 AZ060-1902151200 A100F-160707073 A100F-160908250 A100F-161114700 All units recalled. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
InfuTronix is removing the Nimbus Infusion Pump Systems from the market due to multiple potential failure modes, including battery failure, upstream occlusion, system errors, drug product leakage, high or low flow rate, or damaged pump housing. The device will not be available or supported after June 20, 2024.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- InfuTronix LLC
- Distributor
- Domestic US distribution nationwide. No international distribution.
- Lot
- UDI-DI 00817170020000 Lots A100-150205200 A100-150415015 A100-150430270 A100-150611300 A100-150716620 A100D-1705191000 AZ060-171201564 AZ060-1801021020 AZ060-180609264 AZ060-180626552 AZ060-190104792 AZ060-1902151200 A100F-160707073 A100F-160908250 A100F-161114700 All units recalled
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDANimbus II Infusion System; Nimbus II PainPRO IT1053; Nimbus II Flex IT1062; Nimbus II Plus IT1078; Nimbus IIApril 3, 2024
- FDARoland Tahini; 100% Ground Sesame Seeds; Net WT. 16 OZ. (1 LB.) 454gApril 3, 2024
- FDATestoFREAK Maximize Testosterone Dietary Supplement 60 capsules per dark amber bottle, 100 bottles per caseApril 3, 2024
- FDABoston Scientific POLARSHEATH Steerable Sheath 12F, REF M004CRBS3050April 3, 2024
- FDANordic Naturals Baby s Vitamin D3 liquid, 400 IU (10 mcg) D3, 0.76 fl oz (22.5 mL) DIETARY SUPPLEMENT, darkApril 3, 2024
- FDAstay-safe /Safe Lock Catheter Ext. 12 inApril 3, 2024
Questions about this recall
Was Nimbus Administration Set; Nimbus Flex; Nimbus PainPro (a.k.a. Halo Ambulatory Infusion System); Catalog Number IT1025. Ambulatory Infusion Pump and components recalled?
Yes. FDA published recall Z-1285-2024 on April 3, 2024. Reported hazard: InfuTronix is removing the Nimbus Infusion Pump Systems from the market due to multiple potential failure modes, including battery failure, upstream occlusion, system errors, drug product leakage, high or low flow rate, or damaged pump housing. The device will not be available or supported after June 20, 2024.
What should I do if I have this product?
Voluntary: Firm initiated · Letter